Two gene variants found in African American women may explain why they are more likely to be diagnosed with triple negative breast cancer (TNBC) than white women of European ancestry, according to Weill Cornell Medicine and NewYork-Presbyterian investigators.
Low levels of a clot-busting protein may explain why some people are at higher risk of blood-clotting disorders, according to a new study by Weill Cornell Medicine and NewYork-Presbyterian investigators.
A new federal mandate that requires Medicaid to cover clinical trial costs is an important step to increase racial and ethnic minority participation in research and improve access for low-income patients to advanced treatments.
The 2021 graduates of Weill Cornell Medical College and Weill Cornell Graduate School of Medical Sciences were honored in a livestreamed digital Commencement ceremony on May 20.
Dr. Peter Hotez, M.D. ’87, Ph.D., dean of the National School of Tropical Medicine and professor of pediatrics and of molecular virology and microbiology at Baylor College of Medicine, has been awarded the Weill Cornell Medical College Alumni Association Award of Distinction.
Dr. Eric Huang, a professor of pathology at the University of California San Francisco School of Medicine and physician-scientist who earned his doctorate from the Weill Cornell Graduate School of Medical Sciences in 1993, has been awarded the 2021 Weill Cornell Graduate School Alumni Award of Distinction.
The Weill Cornell Graduate School of Medical Sciences honored the Class of 2021 for their academic achievements during a virtual convocation ceremony May 19.
Molecular characteristics detected in prostate cancers can provide clues that help predict how the disease will progress, according to new research from investigators at Weill Cornell Medicine and NewYork-Presbyterian.
A new understanding of the interaction of two proteins and their role in fat burning and storage may one day have implications for the treatment of obesity and associated diseases such as diabetes and cancer, according to Weill Cornell Medicine investigators.
A team led by researchers at Weill Cornell Medicine and Children’s National Hospital has developed a unique pre-clinical model that enables the study of long-term HIV infection, and the testing of new therapies aimed at curing the disease.
Students from the Weill Cornell Medical College Class of 2021 were recognized for their outstanding achievements, with the winners announced on May 17.
Adding antibiotics to usual care does not improve outcomes for people with the lung disease idiopathic pulmonary fibrosis (IPF), according to the findings from a multi-center, phase 3 clinical trial sponsored by Weill Cornell Medicine.
Weill Cornell Medicine-Qatar welcomed 41 new doctors into the medical profession during commencement on May 5, bringing the total number of physicians educated by the institution to 463 since its inception in 2001.
Scientists have made major advances in understanding and developing treatments for many cancers by identifying genetic mutations that drive the disease. Now a team led by researchers at Weill Cornell Medicine, NewYork-Presbyterian and the New York Genome Center (NYGC) has developed a machine learning technique for detecting other modifications to DNA that have a similar effect.
Using an antibody to block HIV from infecting cells may be an effective and more convenient way to prevent acquisition of HIV, suggests a preliminary study by a multi-institution team of researchers led by investigators from Weill Cornell Medicine and Oregon Health and Science University (OHSU).
The inaugural Women at Weill investment competition recently selected Intellihealth, a comprehensive medical obesity treatment platform co-founded by Dr. Katherine Saunders, assistant professor of clinical medicine at Weill Cornell Medicine, as its first winner.
People who have experienced a cerebral hemorrhage or brain bleed have a two-fold increase in the risk of having an ischemic stroke (caused by an artery blockage) or heart attack, compared with members of the general population.
Despite perceptions that women have made significant gains in medicine, the data tells a different story, said Dr. Julie Silver, in her keynote address on April 29 for Weill Cornell Medicine’s third annual Diversity Week.
